SCHEMBL1614902

SCHEMBL1614902

Cc1nn2c(=O)cc(CNC(=O)C(F)(F)F)[nH]c2c1-c1cccs1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.35
RXFP1 Q9HBX9 1/20 0.35
POLB P06746 3/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 7/20 0.34
KDM4E B2RXH2 5/20 0.34
GAA P10253 4/20 0.34
MAPT P10636 3/20 0.33
LMNA P02545 2/20 0.33
MYC P01106 1/20 0.33
MAX P61244 1/20 0.33
ERCC1 P07992 1/20 0.33
DNASE1 P24855 1/20 0.33
FEN1 P39748 1/20 0.33
ERCC4 Q92889 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GLA P06280 1/20 0.33
HTT P42858 1/20 0.33
ELANE P08246 1/20 0.33
KDM1A O60341 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15909002 0.85 P2RX7 (0.40) POLBKMT2AKDM4ELMNAMYC
SCHEMBL1615068 0.84 MAPK14 (0.37) POLBKMT2AALDH1A1MAPTLMNA
SCHEMBL1279326 0.80 MEN1 (0.38) HPGDPOLBKMT2AALDH1A1KDM4E
SCHEMBL1614735 0.79 PLAT (0.33) HPGDRXFP1KMT2AALDH1A1KDM4E
SCHEMBL15926359 0.79 KDM4E (0.35) HPGDPOLBALDH1A1KDM4EGAA
SCHEMBL1613643 0.78 KDM4E (0.41) HPGDRXFP1KMT2AALDH1A1KDM4E
SCHEMBL1613692 0.77 PARP1 (0.36) POLBKMT2AALDH1A1KDM4EGAA
SCHEMBL1613652 0.76 PARP1 (0.40) HPGDPOLBALDH1A1KDM4EMAPT
SCHEMBL1613688 0.76 PLAT (0.38) POLBKMT2AALDH1A1LMNAMEN1
SCHEMBL1615018 0.75 HCAR2 (0.35) HPGDRXFP1POLBKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 HPGD 569/4885RXFP1 2164/4885POLB 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.